TY  - JOUR 
AU  - Pérez Encinas, Manuel Mateo
PY  - 2014
SN  - 0361-8609
UR  - http://hdl.handle.net/20.500.11940/7774
LA  - eng
TI  - Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?
DO  - 10.1002/ajh.23816
T2  - AMERICAN JOURNAL OF HEMATOLOGY
M2  - E206
VL  - 89
ER  -